Eris Lifesciences Financials
NSE: ERIS | BSE: 540596
₹1,258.90
₹-15.70
(-1.23%)
As on 25-Sep-2026IST
Market cap
₹17,490 Cr
Revenue (TTM)
₹3,230 Cr
P/E Ratio
27.2
P/B Ratio
4.3
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
3,229.67
|
3,129.42
|
2,893.64
|
2,009.15
|
1,685.15
|
1,347.04
|
|
|
|
|
|
|
Total Income
|
3,237.12
|
3,147.87
|
2,912.00
|
2,032.97
|
1,696.30
|
1,373.14
|
|
|
|
|
|
|
Total Expenditure
|
2,090.06
|
2,020.01
|
1,876.44
|
1,334.32
|
1,148.40
|
862.02
|
|
|
|
|
|
|
EBITDA
|
1,139.61
|
1,109.41
|
1,017.20
|
674.83
|
536.75
|
485.03
|
|
|
|
|
|
|
Depreciation
|
281.06
|
279.50
|
315.46
|
182.51
|
117.09
|
64.71
|
|
|
|
|
|
|
EBIT
|
858.55
|
829.91
|
701.74
|
492.32
|
419.66
|
420.32
|
|
|
|
|
|
|
Interest
|
190.64
|
192.67
|
231.29
|
84.80
|
26.17
|
4.22
|
|
|
|
|
|
|
Other Income
|
7.45
|
18.45
|
18.36
|
23.82
|
11.15
|
26.09
|
|
|
|
|
|
|
Exceptional Items
|
-17.24
|
-17.24
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Profit before Tax
|
658.12
|
638.54
|
488.87
|
431.34
|
404.64
|
442.20
|
|
|
|
|
|
|
Provision for Tax
|
-8.80
|
-8.97
|
114.20
|
34.22
|
30.48
|
36.41
|
|
|
|
|
|
|
Profit after Tax
|
666.92
|
647.51
|
374.67
|
397.12
|
374.16
|
405.79
|
|
|
|
|
|
|
Minority Interest
|
-21.81
|
-27.99
|
-22.83
|
-5.07
|
8.00
|
0.32
|
|
|
|
|
|
|
Share of Associate
|
-1.20
|
--
|
--
|
--
|
--
|
--
|
|
|
|
|
|
|
Consolidated Profit
|
643.91
|
619.52
|
351.84
|
392.05
|
382.16
|
406.11
|
|
|
|
|
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
3,902.67
|
3,902.67
|
2,854.36
|
2,586.18
|
2,195.99
|
1,908.31
|
|
|
|
|
|
|
Minority Interest
|
-21.81
|
-7.01
|
417.40
|
635.91
|
24.69
|
-0.11
|
|
|
|
|
|
|
Non-Current Liabilities
|
1,392.75
|
1,149.84
|
2,100.97
|
979.35
|
730.02
|
-78.80
|
|
|
|
|
|
|
Current Liabilities
|
2,077.10
|
2,201.22
|
1,492.79
|
2,608.96
|
521.19
|
283.34
|
|
|
|
|
|
|
Total Liabilities
|
7,365.51
|
7,246.72
|
6,865.52
|
6,810.40
|
3,488.19
|
2,309.78
|
|
|
|
|
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
5,617.77
|
5,582.75
|
5,531.13
|
4,431.47
|
2,629.21
|
1,401.72
|
|
|
|
|
|
|
Current Assets
|
1,539.85
|
1,663.97
|
1,334.39
|
2,378.93
|
842.67
|
711.03
|
|
|
|
|
|
|
Total Assets
|
7,365.51
|
7,246.72
|
6,865.52
|
6,810.40
|
3,488.19
|
2,309.78
|
|
|
|
|
|
|
Total Debt*
|
--
|
2,309.68
|
2,421.66
|
2,735.27
|
830.02
|
45.01
|
|
|
|
|
|
|
Net Current Assets
|
-537.25
|
-537.25
|
-158.40
|
-230.03
|
321.49
|
427.68
|
|
|
|
|
|
|
Contingent Liabilities
|
--
|
51.57
|
51.96
|
53.95
|
28.39
|
24.51
|
|
|
|
|
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
537.99
|
1,065.01
|
486.01
|
291.74
|
378.26
|
|
|
|
|
|
|
Cash Flow from Investing Activities
|
--
|
-369.46
|
-79.97
|
-1,854.52
|
-982.10
|
-319.61
|
|
|
|
|
|
|
Cash from Financing Activities
|
--
|
-313.53
|
-881.32
|
1,379.68
|
688.03
|
-44.70
|
|
|
|
|
|
|
Net Cash Inflow / Outflow
|
--
|
-145.00
|
103.72
|
11.17
|
-2.34
|
13.96
|
|
|
|
|
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
47.61
|
44.73
|
25.83
|
28.83
|
28.10
|
29.88
|
|
|
|
|
|
|
Cash EPS (₹)
|
46.41
|
66.93
|
50.67
|
42.62
|
36.12
|
34.61
|
|
|
|
|
|
|
Adjusted Book Value (₹)
|
290.65
|
280.75
|
208.83
|
189.79
|
161.28
|
140.25
|
|
|
|
|
|
|
Dividend per Share (₹)
|
--
|
--
|
7.35
|
--
|
7.35
|
6.01
|
|
|
|
|
|
|
Cash Flow per Share (₹)
|
--
|
38.84
|
78.19
|
35.74
|
21.45
|
27.83
|
|
|
|
|
|
|
Free Cash Flow per Share (₹)
|
--
|
12.43
|
48.54
|
25.86
|
-38.66
|
23.51
|
|
|
|
|
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
14.47
|
13.59
|
12.37
|
17.30
|
25.29
|
|
|
|
|
|
|
ROE (%)
|
18.75
|
19.23
|
13.81
|
16.64
|
18.25
|
23.33
|
|
|
|
|
|
|
ROA (%)
|
9.26
|
9.18
|
5.48
|
7.72
|
13.40
|
21.27
|
|
|
|
|
|
|
EBIT Margin (%)
|
26.58
|
26.52
|
24.25
|
24.50
|
24.90
|
31.20
|
|
|
|
|
|
|
Net Margin (%)
|
20.60
|
20.57
|
12.87
|
19.53
|
22.06
|
29.55
|
|
|
|
|
|
|
Cash Profit Margin (%)
|
--
|
28.49
|
23.21
|
27.41
|
27.83
|
33.73
|
|
|
|
|
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
9.59
|
8.15
|
44.02
|
19.23
|
25.10
|
11.15
|
|
|
|
|
|
|
EBIT Growth (%)
|
16.84
|
18.26
|
42.54
|
17.31
|
-0.16
|
8.40
|
|
|
|
|
|
|
Net Profit Growth (%)
|
69.34
|
72.82
|
-5.65
|
6.14
|
-7.79
|
14.26
|
|
|
|
|
|
|
EPS Growth (%)
|
64.38
|
73.16
|
-10.39
|
2.58
|
-5.94
|
14.23
|
|
|
|
|
|
|
Book Value Growth (%)
|
--
|
36.71
|
10.19
|
17.69
|
15.04
|
21.24
|
|
|
|
|
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
27.16
|
29.02
|
54.83
|
29.18
|
20.36
|
23.06
|
|
|
|
|
|
|
Price / Book Value
|
4.34
|
4.62
|
6.78
|
4.43
|
3.55
|
4.91
|
|
|
|
|
|
|
Dividend Yield (%)
|
--
|
--
|
0.52
|
--
|
1.28
|
0.87
|
|
|
|
|
|
|
EV/EBITDA
|
17.20
|
17.93
|
20.75
|
18.29
|
15.61
|
18.31
|
|
|
|
|
|
|
Close Price (₹)
|
1,433.50
|
1,297.20
|
1,417.35
|
843.35
|
572.10
|
688.70
|
|
|
|
|
|
|
High Price (₹)
|
1,887.65
|
1,910.00
|
1,593.90
|
971.90
|
749.85
|
863.15
|
|
|
|
|
|
|
Low Price (₹)
|
1,200.00
|
1,097.20
|
815.50
|
565.00
|
550.90
|
576.50
|
|
|
|
|
|
|
Market Cap (₹ Cr)
|
17,490.08
|
17,980.08
|
19,292.77
|
11,440.30
|
7,779.32
|
9,366.94
|
|
|
|
|
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.24
|
0.59
|
0.85
|
1.06
|
0.38
|
0.02
|
|
|
|
|
|
|
Short term debt to equity ratio
|
--
|
0.12
|
0.14
|
0.51
|
0.03
|
0.00
|
|
|
|
|
|
|
Current Ratio
|
0.74
|
0.76
|
0.89
|
0.91
|
1.62
|
2.51
|
|
|
|
|
|
|
Quick Ratio
|
0.53
|
0.56
|
0.67
|
0.84
|
1.41
|
2.16
|
|
|
|
|
|
|
Interest Coverage
|
4.45
|
4.31
|
3.11
|
6.09
|
16.46
|
105.81
|
|
|
|
|
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
21.07
|
21.74
|
15.85
|
21.00
|
17.37
|
11.95
|
|
|
|
|
|
|
Asset Turnover
|
0.45
|
0.46
|
0.43
|
0.41
|
0.63
|
0.73
|
|
|
|
|
|
|
Receivable days
|
--
|
63.88
|
54.06
|
61.68
|
46.91
|
39.44
|
|
|
|
|
|
|
Inventory Days
|
--
|
43.27
|
32.16
|
27.66
|
25.78
|
27.78
|
|
|
|
|
|
|
Payable days
|
--
|
151.85
|
140.91
|
165.04
|
125.63
|
155.58
|
|
|
|
|
|
|
Cash Conversion Cycle
|
--
|
-44.70
|
-54.69
|
-75.70
|
-52.94
|
-88.36
|
|
|
|
|
|
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
